Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Cognitive outcomes following epilepsy in infancy: A longitudinal community-based study.

O'Reilly H, Eltze C, Bennett K, Verhaert K, Webb R, Merrett A, Scott RC, Whitney A, Helen Cross J, de Haan M.

Epilepsia. 2018 Dec;59(12):2240-2248. doi: 10.1111/epi.14589. Epub 2018 Nov 5.

PMID:
30395354
2.

Attitudes of newly qualified doctors towards a career in general practice: a qualitative focus group study.

Merrett A, Jones D, Sein K, Green T, Macleod U.

Br J Gen Pract. 2017 Apr;67(657):e253-e259. doi: 10.3399/bjgp17X690221.

3.

Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activity.

Roughley SD, Browne H, Macias AT, Benwell K, Brooks T, D'Alessandro J, Daniels Z, Dugdale S, Francis G, Gibbons B, Hart T, Haymes T, Kennett G, Lightowler S, Matassova N, Mansell H, Merrett A, Misra A, Padfield A, Parsons R, Pratt R, Robertson A, Simmonite H, Tan K, Walls SB, Wong M.

Bioorg Med Chem Lett. 2012 Jan 15;22(2):901-6. doi: 10.1016/j.bmcl.2011.12.032. Epub 2011 Dec 13.

PMID:
22209458
4.

A collaborative approach to fall prevention.

Merrett A, Thomas P, Stephens A, Moghabghab R, Gruneir M.

Can Nurse. 2011 Oct;107(8):24-9.

PMID:
22128708
5.

"I look forward. I feel insecure but I am ok with it". The experience of young HIV+ people attending transition preparation events: a qualitative investigation.

Campbell T, Beer H, Wilkins R, Sherlock E, Merrett A, Griffiths J.

AIDS Care. 2010 Feb;22(2):263-9. doi: 10.1080/09540120903111460.

PMID:
20390505
6.

Discovery and optimization of potent and selective functional antagonists of the human adenosine A2B receptor.

Bedford ST, Benwell KR, Brooks T, Chen I, Comer M, Dugdale S, Haymes T, Jordan AM, Kennett GA, Knight AR, Klenke B, LeStrat L, Merrett A, Misra A, Lightowler S, Padfield A, Poullennec K, Reece M, Simmonite H, Wong M, Yule IA.

Bioorg Med Chem Lett. 2009 Oct 15;19(20):5945-9. doi: 10.1016/j.bmcl.2009.08.040. Epub 2009 Aug 14.

PMID:
19733067
7.

Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperone.

Brough PA, Barril X, Borgognoni J, Chene P, Davies NG, Davis B, Drysdale MJ, Dymock B, Eccles SA, Garcia-Echeverria C, Fromont C, Hayes A, Hubbard RE, Jordan AM, Jensen MR, Massey A, Merrett A, Padfield A, Parsons R, Radimerski T, Raynaud FI, Robertson A, Roughley SD, Schoepfer J, Simmonite H, Sharp SY, Surgenor A, Valenti M, Walls S, Webb P, Wood M, Workman P, Wright L.

J Med Chem. 2009 Aug 13;52(15):4794-809. doi: 10.1021/jm900357y.

PMID:
19610616
8.

Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidines.

Gillespie RJ, Bamford SJ, Botting R, Comer M, Denny S, Gaur S, Griffin M, Jordan AM, Knight AR, Lerpiniere J, Leonardi S, Lightowler S, McAteer S, Merrett A, Misra A, Padfield A, Reece M, Saadi M, Selwood DL, Stratton GC, Surry D, Todd R, Tong X, Ruston V, Upton R, Weiss SM.

J Med Chem. 2009 Jan 8;52(1):33-47. doi: 10.1021/jm800961g.

PMID:
19072055
9.
10.

Calcium metabolism in subjects living with a permanent ileostomy.

Kennedy HJ, Compston J, Heynen G, Kanis JA, Merrett AL, Truelove SC, Warner GT.

Digestion. 1983;26(3):131-6.

PMID:
6852394
11.

Ranitidine in duodenal ulcer: incidence of healing and effect of smoking.

Korman MG, Hansky J, Merrett AC, Schmidt GT.

Dig Dis Sci. 1982 Aug;27(8):712-5.

PMID:
6284459
13.

Failure to heal D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3.

Cundy T, Kanis JA, Heynen G, Earnshaw M, Clemens TL, O'Riordan JL, Merrett AL, Compston JE.

Br Med J (Clin Res Ed). 1982 Mar 20;284(6319):883-5. No abstract available.

14.

Cimetidine-induced erythema annulare centrifugum: no cross-sensitivity with ranitidine.

Merrett AC, Marks R, Dudley FJ.

Br Med J (Clin Res Ed). 1981 Sep 12;283(6293):698. No abstract available.

15.
16.

Plasma 25-hydroxyvitamin D concentrations in preterm infants receiving oral vitamin D supplements.

Robinson MJ, Merrett AL, Tetlow VA, Compston JE.

Arch Dis Child. 1981 Feb;56(2):144-5.

17.

Privational and malabsorption metabolic bone disease: plasma vitamin D metabolite concentrations and their relationship to quantitative bone histology.

Compston JE, Vedi S, Merrett AL, Clemens TL, O'Riordan JL, Woodhead JS.

Metab Bone Dis Relat Res. 1981;3(3):165-70.

PMID:
6897097
18.

Osteomalacia developing during treatment of osteoporosis with sodium fluoride and vitamin D.

Compston JE, Chadha S, Merrett AL.

Br Med J. 1980 Oct 4;281(6245):910-1. No abstract available.

19.

Treatment of bone disease after jejunoileal bypass for obesity with oral 1 alpha-hydroxyvitamin D3.

Compston JE, Horton LW, Laker MF, Merrett AL, Woodhead JS, Gazet JC, Pilkington TR.

Gut. 1980 Aug;21(8):669-74.

20.

Vitamin D prophylaxis and osteomalacia in chronic cholestatic liver disease.

Compston JE, Crowe JP, Wells IP, Horton LW, Hirst D, Merrett AL, Woodhead JS, Williams R.

Dig Dis Sci. 1980 Jan;25(1):28-32.

PMID:
7353448

Supplemental Content

Loading ...
Support Center